Acción NSPR INSPIREMD, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas InspireMD, Inc.

Acciones

NSPR

US45779A8466

Diferido Nasdaq
Otros sitios de cotización
 22:30:01 13/05/2024 		Varia. Cinco días. Varia. 1 de enero.
2,4 USD +7,38 % Gráfico intradía de InspireMD, Inc. +13,20 % -14,59 %
06/03 Transcript : InspireMD, Inc., Q4 2023 Earnings Call, Mar 06, 2024
05/03 InspireMD, Inc. informa de los resultados del ejercicio finalizado el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Earnings Flash (NSPR) INSPIREMD Posts Q1 Revenue $1.5M, vs. Street Est of $1.9M
InspireMD : Reports First Quarter 2024 Financial Results and Provides Business Update
InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th
InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
Earnings Flash (NSPR) INSPIREMD Posts Q4 Revenue $1.8M
InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
InspireMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Business Update on Wednesday, March 6th
InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neuroprotection System
InspireMD Gets CE Mark Recertification From the European Union
InspireMD Receives CE Mark Recertification Under EU’s New Medical Device Regulation (MDR) Regulatory Framework
InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America
InspireMD, Inc. Announces Appointment of Pete Ligotti as Executive Vice President and General Manager of North America
InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard™ Neuroprotection System
InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions
InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions
Earnings Flash (NSPR) INSPIREMD Reports Q3 Revenue $1.6M
InspireMD Reports Third Quarter 2023 Financial Results and Provides Business Update
InspireMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción NSPR
  4. Noticias InspireMD, Inc.
  5. Otros idiomas